Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Non-small Cell Lung Cancer
Clinical trial register · China

Non-small Cell Lung Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 07 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Shanghai 12 Wuhan 1 Nanchang 1 Ürümqi 1 Wenzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai12 Wuhan1 Nanchang1 Ürümqi1 Wenzhou1
All 12 locations
Target enrolment
to

Non-small Cell Lung Cancer trials in China

12 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Pulsed Field Ablation for the Treatment of Malignant Lung Tumors
NCT07889297Non-Small Cell Lung Cancer, Pulmonary Metastases
Shanghai Chest Hospital
Not applicable
15
Shanghai
2026-10
Not yet open
Segmentectomy Versus Lobectomy for Deep Solid-Dominant Early-Stage NSCLC
NCT07698990Non-Small Cell Lung Cancer, Stage IA Non-Small Cell Lung Cancer
Shanghai Chest Hospital
Not applicable
1,200
Shanghai
2026-08-21
Recruiting
Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)
NCT07564557Non-small Cell Lung Cancer, Early-stage Lung Cancer, Deep-seated Lung Nodules, Solid-dominant Lung Cancer
Shanghai Chest Hospital
Not applicable
89
Shanghai
2026-04-01
Active, closed
Shanghai Chest Hospital
Phase 2/3
97
Shanghai
2025-06-03
Not yet open
Shanghai Chest Hospital
Not applicable
134
Wuhan, Nanchang, Shanghai, Ürümqi, Wenzhou
2024-09-01
By invitation
Shanghai Chest Hospital
Observational
500
Shanghai
2024-08-16
Recruiting
Shanghai Chest Hospital
Phase 2
54
Shanghai
2024-04-02
Recruiting
Shanghai Chest Hospital
Observational
250
Shanghai
2023-10-01
Active, closed
Shanghai Chest Hospital
Observational
305
Hefei, Xiamen, Guangzhou, Harbin, Zhengzhou, Changsha, Jinan, Shanghai
2023-05-08
Recruiting
Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
NCT07632365Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer, Unresectable Stage III NSCLC
Shanghai Chest Hospital
Phase 1/2
108
Shanghai
2022-10-09
Recruiting
Shanghai Chest Hospital
Observational
250
Shanghai
2016-07-21
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 7 November 2026. https://priyalifescience.com/clinical-trials-china/condition/non-small-cell-lung-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 07 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Non-small Cell Lung Cancer that also match the filters currently applied.

How many Non-small Cell Lung Cancer trials are recruiting in China?

6 of the 12 studies on this page are recruiting new participants as of the 07 Nov 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Non-small Cell Lung Cancer), 12 studies
PhaseStudiesRecruitingShare
Observational5341.7%
Not applicable4133.3%
Phase 1/2118.3%
Phase 2118.3%
Phase 2/3108.3%

Most active sponsors

Lead sponsors with the most studies (Non-small Cell Lung Cancer)
Lead sponsorStudiesRecruiting
Shanghai Chest Hospital126
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.